A young pharmaceutical startup wants to develop a groundbreaking new treatment for a relatively common cancer. Yet it struggles to find funding. That's because the startup in question is Antiva Biosciences, and the cancer it aims to treat is cervical cancer. Stat reported Thursday on the company's struggles to attract investment, as well as its constant fight to receive buy-in from male doctors, quoting Antiva's top executives discussing frankly their perceptions of the problem: "It's very safe to say that we got more traction in [venture capital] firms where there was a woman partner who was in a decision-making role," Antiva CEO Gail Maderis told Stat. Antiva's proposal is to replace the most common treatment prescribed for women who develop the precancerous cervical lesions that result from being infected with HPV, which is surgery.

BING NEWS:
  • How Can We Prevent Cervical Cancer? A Review By Doctors
    Expert opinion from Kanne Karthik MBBS · 3 years of experience · India If you are 11-12years old get vaccinated for HPV infection 3doses over 6months (Recommended at age 11-12years, but approved for 9 ...
    04/4/2024 - 10:28 am | View Link
  • Cervical cancer rates are climbing among low-income women. Here’s why.
    Story at a glance Cervical cancer rates, long on the decline, are climbing among low-income women in the United States. Cervical cancer was once the leading cause of death for American women, ...
    03/25/2024 - 11:00 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News